Atlas Trials

Vascular Effects of Rosiglitazone Versus Glyburide in Type 2 Diabetic Patients

Clinical trial NCT00123643 · COMPLETED

Trial details

NCT number
NCT00123643
Sponsor
St. Paul Heart Clinic
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Type 2 Diabetes Mellitus
Start date
2003-05-01
Primary completion
2005-12-01
Enrollment
36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.